September 8, 2015
Financing will advance Sanifit's lead drug candidate through phase IIb as a treatment for cardiovascular diseases linked to calcification and throughphase II/III for calciphylaxis.Palma de Mallorca, Spain, September 8, 2015 - Laboratoris Sanifit S.L., a clinical-stagebiopharmaceutical company, today announces that it has raised ?36.6M ($41.3M) in a SeriesC financing round. The company is focused on the...


90 million to 18 Talented Researchers
19. October 2020
Søren Dinesen Lumdbeckfonden
Psychiatry research leads to prestigious science prize
13. October 2020
Christian Sandøe Musaeus Lundbeckfonden
Concentrating on Dementia
13. October 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge